Search company, investor...

Predict your next investment

Venture Capital
indacocapital.com

Investments

11

About Indaco Capital

Indaco Capital is a venture capital firm based in China that invests in healthcare-related fields.

Headquarters Location

2305, Block A, Phoenix Landmark No. 5 Shuguang Xilijia, Chaoyang District

Beijing, Beijing,

China

+86 (010) 57623688

Want to inform investors similar to Indaco Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Indaco Capital Investments

11 Investments

Indaco Capital has made 11 investments. Their latest investment was in ReLive Biotechnologies as part of their Series A on January 1, 2023.

CBI Logo

Indaco Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/25/2023

Series A

ReLive Biotechnologies

$36M

Yes

1

1/17/2023

Series A

ReLive

$36M

No

1

6/13/2022

Seed VC

Cambrian Zhiyuan

Yes

1

3/21/2022

Seed VC

Subscribe to see more

Subscribe to see more

10

2/22/2022

Seed VC

Subscribe to see more

Subscribe to see more

10

Date

1/25/2023

1/17/2023

6/13/2022

3/21/2022

2/22/2022

Round

Series A

Series A

Seed VC

Seed VC

Seed VC

Company

ReLive Biotechnologies

ReLive

Cambrian Zhiyuan

Subscribe to see more

Subscribe to see more

Amount

$36M

$36M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.